• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

金属蛋白酶9(MMP-9)和组织金属蛋白酶1(TIMP-1)基因的转录活性作为缺血性心脏病所致心力衰竭的诊断和预后标志物

Transcriptional Activity of Metalloproteinase 9 (MMP-9) and Tissue Metalloproteinase 1 (TIMP-1) Genes as a Diagnostic and Prognostic Marker of Heart Failure Due to Ischemic Heart Disease.

作者信息

Korzeń Dariusz, Sierka Oskar, Dąbek Józefa

机构信息

Provincial Specialist Hospital Megrez Sp. z o. o., Edukacji Street 102, 43-100 Tychy, Poland.

Student Research Group at the Department of Cardiology, Department of Cardiology, Faculty of Health Sciences in Katowice, Medical University of Silesia in Katowice, Ziołowa Street 45/47, 40-635 Katowice, Poland.

出版信息

Biomedicines. 2023 Oct 13;11(10):2776. doi: 10.3390/biomedicines11102776.

DOI:10.3390/biomedicines11102776
PMID:37893149
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10604598/
Abstract

The most common cause of heart failure (HF) is coronary artery disease (CAD). The aim of this study was to evaluate the transcriptional activity of the () and () genes in a study group of patients with HF due to CAD and in the control group, as well as assess the transcriptional activity of the examined genes, taking into account the number of affected coronary arteries and the severity of heart failure. The study group consisted of a total of 150 (100%) patients. The material for the study was peripheral blood, and molecular tests were performed using the quantitative QRT-PCR technique. The transcriptional activity of the gene was significantly higher in the group of patients with CAD and HF. It was also significantly higher with the progression of heart failure. gene transcriptional activity was significantly lower with the advancement of heart failure. The transcriptional activity of the and genes differentiated the examined patients. The severity of HF, and a significant increase in the QRT-PCR transcriptional activity of the gene with a simultaneous decrease in the activity of the gene, makes them useful diagnostic and prognostic markers in clinical practice.

摘要

心力衰竭(HF)最常见的病因是冠状动脉疾病(CAD)。本研究的目的是评估因CAD导致HF的研究组患者和对照组中()基因和()基因的转录活性,并考虑受影响冠状动脉的数量和心力衰竭的严重程度来评估所检测基因的转录活性。研究组共有150名(100%)患者。研究材料为外周血,分子检测采用定量QRT-PCR技术。CAD合并HF患者组中基因的转录活性显著更高。随着心力衰竭的进展,其转录活性也显著升高。随着心力衰竭的进展,基因转录活性显著降低。基因和基因的转录活性区分了所检测的患者。HF的严重程度,以及基因QRT-PCR转录活性的显著增加同时基因活性的降低,使其在临床实践中成为有用的诊断和预后标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cce3/10604598/c6818d1418b1/biomedicines-11-02776-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cce3/10604598/1a4d10ff9b56/biomedicines-11-02776-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cce3/10604598/00d558a3fe50/biomedicines-11-02776-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cce3/10604598/7b159dd0953a/biomedicines-11-02776-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cce3/10604598/07e9bb5add79/biomedicines-11-02776-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cce3/10604598/48518907fd2c/biomedicines-11-02776-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cce3/10604598/c6818d1418b1/biomedicines-11-02776-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cce3/10604598/1a4d10ff9b56/biomedicines-11-02776-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cce3/10604598/00d558a3fe50/biomedicines-11-02776-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cce3/10604598/7b159dd0953a/biomedicines-11-02776-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cce3/10604598/07e9bb5add79/biomedicines-11-02776-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cce3/10604598/48518907fd2c/biomedicines-11-02776-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cce3/10604598/c6818d1418b1/biomedicines-11-02776-g006.jpg

相似文献

1
Transcriptional Activity of Metalloproteinase 9 (MMP-9) and Tissue Metalloproteinase 1 (TIMP-1) Genes as a Diagnostic and Prognostic Marker of Heart Failure Due to Ischemic Heart Disease.金属蛋白酶9(MMP-9)和组织金属蛋白酶1(TIMP-1)基因的转录活性作为缺血性心脏病所致心力衰竭的诊断和预后标志物
Biomedicines. 2023 Oct 13;11(10):2776. doi: 10.3390/biomedicines11102776.
2
Risk Factors Association with Transcriptional Activity of Metalloproteinase 9 (MMP-9) and Tissue Inhibitor of Metalloproteinases 1 (TIMP-1) Genes in Patients with Heart Failure.心力衰竭患者中与金属蛋白酶9(MMP-9)和金属蛋白酶组织抑制剂1(TIMP-1)基因转录活性相关的危险因素
Biomedicines. 2024 Mar 7;12(3):601. doi: 10.3390/biomedicines12030601.
3
Can the expression of the metalloproteinase 9 gene and its inhibitor be considered as markers of heart failure?金属蛋白酶 9 基因及其抑制剂的表达能否作为心力衰竭的标志物?
Minerva Cardiol Angiol. 2021 Apr;69(2):172-177. doi: 10.23736/S2724-5683.20.05202-0. Epub 2020 Jul 8.
4
Transcription activity of MMP-2 and MMP-9 metalloproteinase genes and their tissue inhibitor (TIMP-2) in acute coronary syndrome patients.急性冠状动脉综合征患者中基质金属蛋白酶-2和基质金属蛋白酶-9基因及其组织抑制剂(TIMP-2)的转录活性
J Postgrad Med. 2013 Apr-Jun;59(2):115-20. doi: 10.4103/0022-3859.113836.
5
MMP-2 and TIMP-2 in Patients with Heart Failure and Chronic Kidney Disease.心力衰竭合并慢性肾脏病患者的基质金属蛋白酶-2和金属蛋白酶组织抑制因子-2
Open Med (Wars). 2018 Jun 14;13:237-246. doi: 10.1515/med-2018-0037. eCollection 2018.
6
Effect of matrix metalloproteinase and their inhibitors on atrial myocardial structural remodeling.基质金属蛋白酶及其抑制剂对心房心肌结构重构的影响。
J Cardiovasc Med (Hagerstown). 2013 Apr;14(4):265-9. doi: 10.2459/JCM.0b013e328354e458.
7
Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.梗死大鼠心力衰竭进展过程中基质金属蛋白酶和组织抑制剂表达的演变
Cardiovasc Res. 2000 May;46(2):307-15. doi: 10.1016/s0008-6363(00)00029-8.
8
[Mechanism of tanshinone II A inhibiting myocardial remodeling by Galectin-3].丹参酮IIA通过半乳糖凝集素-3抑制心肌重构的机制
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022 Jun;34(6):640-645. doi: 10.3760/cma.j.cn121430-20220309-00232.
9
Evaluation of MMP-9, IL-6, TNF-α levels and peripheral blood mononuclear cells genes expression of MMP-9 and TIMP-1 in Iranian patients with coronary artery disease.伊朗冠心病患者中基质金属蛋白酶-9(MMP-9)、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)水平以及外周血单个核细胞中MMP-9和金属蛋白酶组织抑制因子-1(TIMP-1)基因表达的评估
J Cardiovasc Thorac Res. 2023;15(4):223-230. doi: 10.34172/jcvtr.2023.31844. Epub 2023 Dec 30.
10
Association between matrix metalloproteinase-9 and worsening heart failure events in patients with chronic heart failure.慢性心力衰竭患者中基质金属蛋白酶-9与心力衰竭恶化事件之间的关联。
ESC Heart Fail. 2017 Aug;4(3):321-330. doi: 10.1002/ehf2.12137. Epub 2017 Feb 10.

引用本文的文献

1
Can Gene Expression Differentiate Patients With Heart Failure due to Coronary Heart Disease From Patients With Coronary Disease Without Heart Failure?基因表达能否区分冠心病所致心力衰竭患者与无心力衰竭的冠心病患者?
J Cell Mol Med. 2025 Sep;29(17):e70727. doi: 10.1111/jcmm.70727.
2
Matrix Metalloproteinases: Pathophysiologic Implications and Potential Therapeutic Targets in Cardiovascular Disease.基质金属蛋白酶:心血管疾病中的病理生理意义及潜在治疗靶点
Biomolecules. 2025 Apr 17;15(4):598. doi: 10.3390/biom15040598.
3
Redox Homeostasis and Molecular Biomarkers in Precision Therapy for Cardiovascular Diseases.

本文引用的文献

1
Sex Differences in Acute Coronary Syndromes: A Global Perspective.急性冠状动脉综合征中的性别差异:全球视角
J Cardiovasc Dev Dis. 2022 Jul 27;9(8):239. doi: 10.3390/jcdd9080239.
2
Matrix Metalloproteinase 2 as a Pharmacological Target in Heart Failure.基质金属蛋白酶2作为心力衰竭的一个药理学靶点。
Pharmaceuticals (Basel). 2022 Jul 25;15(8):920. doi: 10.3390/ph15080920.
3
Properties and Functions of Fibroblasts and Myofibroblasts in Myocardial Infarction.心肌梗死中成纤维细胞和肌成纤维细胞的特性和功能。
心血管疾病精准治疗中的氧化还原稳态与分子生物标志物
Antioxidants (Basel). 2024 Sep 25;13(10):1163. doi: 10.3390/antiox13101163.
4
Unveiling TIMPs: A Systematic Review of Their Role as Biomarkers in Atherosclerosis and Coronary Artery Disease.揭示金属蛋白酶组织抑制因子:对其作为动脉粥样硬化和冠状动脉疾病生物标志物作用的系统评价。
Diseases. 2024 Aug 2;12(8):177. doi: 10.3390/diseases12080177.
5
Matrix metallopeptidase 9 contributes to the beginning of plaque and is a potential biomarker for the early identification of atherosclerosis in asymptomatic patients with diabetes.基质金属蛋白酶9促成斑块的形成,是早期识别无症状糖尿病患者动脉粥样硬化的潜在生物标志物。
Front Endocrinol (Lausanne). 2024 Apr 10;15:1369369. doi: 10.3389/fendo.2024.1369369. eCollection 2024.
6
Risk Factors Association with Transcriptional Activity of Metalloproteinase 9 (MMP-9) and Tissue Inhibitor of Metalloproteinases 1 (TIMP-1) Genes in Patients with Heart Failure.心力衰竭患者中与金属蛋白酶9(MMP-9)和金属蛋白酶组织抑制剂1(TIMP-1)基因转录活性相关的危险因素
Biomedicines. 2024 Mar 7;12(3):601. doi: 10.3390/biomedicines12030601.
Cells. 2022 Apr 20;11(9):1386. doi: 10.3390/cells11091386.
4
Relationships between Circulating Matrix Metalloproteinases, Tissue Inhibitor TIMP-2, and Renal Function in Patients with Myocarditis.心肌炎患者循环基质金属蛋白酶与组织抑制剂 TIMP-2 及肾功能的关系。
Kidney Blood Press Res. 2021;46(6):749-757. doi: 10.1159/000519594. Epub 2021 Nov 19.
5
Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association.心力衰竭的通用定义和分类:美国心力衰竭学会、欧洲心脏病学会心力衰竭协会、日本心力衰竭学会和心力衰竭通用定义写作委员会的报告:得到加拿大心力衰竭学会、印度心力衰竭协会、澳大利亚和新西兰心脏病学会以及中国心力衰竭协会的认可。
Eur J Heart Fail. 2021 Mar;23(3):352-380. doi: 10.1002/ejhf.2115. Epub 2021 Mar 3.
6
Complex Relationship Between Cardiac Fibroblasts and Cardiomyocytes in Health and Disease.心脏成纤维细胞与心肌细胞在健康和疾病中的复杂关系。
J Am Heart Assoc. 2021 Feb;10(5):e019338. doi: 10.1161/JAHA.120.019338. Epub 2021 Feb 15.
7
Identification of biomarker panels as predictors of severity in coronary artery disease.识别生物标志物谱作为冠心病严重程度的预测因子。
J Cell Mol Med. 2021 Feb;25(3):1518-1530. doi: 10.1111/jcmm.16244. Epub 2020 Dec 31.
8
Discovery of potent and specific inhibitors targeting the active site of MMP-9 from the engineered SPINK2 library.从工程化的 SPINK2 文库中发现针对 MMP-9 活性位点的有效且特异性抑制剂。
PLoS One. 2020 Dec 29;15(12):e0244656. doi: 10.1371/journal.pone.0244656. eCollection 2020.
9
Correlation between serum matrix metalloproteinase and myocardial fibrosis in heart failure patients with reduced ejection fraction: A retrospective analysis.血清基质金属蛋白酶与射血分数降低心力衰竭患者心肌纤维化的相关性:一项回顾性分析。
Anatol J Cardiol. 2020 Nov;24(5):303-308. doi: 10.14744/AnatolJCardiol.2020.54937.
10
Complexity and plasticity of cardiac cellular composition.心脏细胞组成的复杂性和可塑性。
Nat Rev Cardiol. 2020 Dec;17(12):759. doi: 10.1038/s41569-020-00464-6.